Our Leadership .
President and CEO Jamey Butcher
"What I love about international development is collaborating with people who have different ideas and perspectives to find solutions and share experiences about things that work."
Since joining Chemonics in 1998, President and CEO Jamey Butcher has served across a variety of roles and regions. Most recently, Mr. Butcher oversaw Chemonics’ global health and supply chain portfolio. In that capacity, he led efforts to implement sustainable supply chains, improve health service delivery, and scale up innovative approaches in developing country environments. He also championed the development of Chemonics’ knowledge sharing and learning hub that provides continual learning opportunities for Chemonics’ global network of more than 5,000 employees. Previously, Mr. Butcher served as senior vice president of the Europe and Eurasia, Global Health, Africa, and then East Africa business units. In addition to diversifying and expanding the company’s portfolio, he developed a quality assurance approach to new business and trained staff in innovative enterprise development methods. While providing strategic management and operational oversight of Chemonics, Mr. Butcher draws from experience as a private sector development specialist with more than 20 years of experience in Eurasia, Latin America, and Asia. He has conducted technical assignments on international trade, competitiveness, and micro-, small, and medium enterprise development. He also served as chief of party of the Armenia Micro Enterprise Development Initiative (MEDI). Mr. Butcher received an M.A. from American University in international political economy and a B.A. in political science from Colorado State University.
by Jamey Butcher
This post originally appeared on the USGLC blog on July 8, 2020. Despite the multiple mechanisms that exist to respond to infectious disease threats, including the World Health Organization’s International Health Regulations and the Global Health Security Agenda (GHSA), only 11 percent of countries have plans to dispense medical countermeasures during health emergencies and 27 percent have an updated…
The full implications of the COVID-19 pandemic are yet to be determined, but it has disrupted nearly every aspect of socioeconomic activity at a breadth and scale not seen in modern memory. Now activities that once seemed routine — school, work, travel, errands, and social gatherings —present serious health risks, and the resulting lockdown is…
In the age of Amazon, efficient global commercial supply chains are essential for successful companies to deliver their products to consumers. These companies use sophisticated analytics, have end-to-end visibility in all aspects of their supply chain operations right down to the last mile, and operate with a level of precision that their customers demand. As…
Jamey Butcher, CEO at Chemonics International, talks about why his company has launched a new subsidiary, and how it is changing in response to the pandemic and localization.
In this Brunswick Review interview by Stewart Jones, Jamey Butcher is interviewed about how Chemonics reimagined a global health supply chain that enables medicine to reach the most remote corners of the world.
In this interview by Michael Igoe, Devex speaks with Jamey Butcher about how Chemonics responded to early challenges with the $9.5 billion global health supply chain project.
Q&A with Jamey Butcher (Podcast): Delivering Life-Saving Medical Commodities in the Developing World
Alexandra Gonzalez, student ambassador for Harvard University's Center for International Development, interviews Jamey Butcher about the role Chemonics plays in international development and the USAID Global Health Supply Chain-Procurement and Supply Management program.